See bold text below:
For the purpose of this rule the commissioner adopts the definitions as set forth in Section 31A-1-301, 29 CFR 2560.503-1(m), and the following:
(1)(a) “Adverse benefit determination” means, for an accident and health insurance policy other than a health benefit plan, any of the following: a denial, reduction, or termination of, or a failure to provide or make payment, in whole or in part, for a benefit, including any such denial, reduction, termination, or failure to provide or make payment that is based on a determination of an insured’s eligibility to participate in a plan, and including, with respect to group health plans, a denial, reduction, or termination of or failure to provide or make payment, in whole or in part, for a benefit resulting from the application of any utilization review, as well as a failure to cover an item or service for which benefits are otherwise experimental or investigational or not medically necessary or appropriate; and
(b)(i) “Adverse benefit determination” means, for a health benefit plan:
(A) based on the insurer’s requirements for medical necessity, appropriateness, health care setting, level of care, or effectiveness of a covered benefit, the:
(I) denial of a benefit;
(II) reduction of a benefit;
(III) termination of a benefit; or
(IV) failure to provide or make payment, in whole or part, for a benefit; or
(B) rescission of coverage.
(ii) “Adverse benefit determination” includes:
(A) denial, reduction, termination, or failure to provide or make payment that is based on a determination of an insured’s eligibility to participate in a health benefit plan;
(B) failure to provide or make payment, in whole or part, for a benefit resulting from the application of a utilization review; and
(C) failure to cover an item or service for which benefits are otherwise provided because it is determined to be:
(II) investigational; or
(III) not medically necessary or appropriate.
(2) “Claim File” means any record either in its original form or as recorded by any process which can accurately and reliably reproduce the original material regarding the claim, its investigation, adjustment and settlement.
(3) “Claim Representative” means any individual, corporation, association, organization, partnership, or other legal entity authorized to represent an insurer with respect to a claim, whether or not licensed within the State of Utah to do so.
(4) “Claimant” means an insured, or legal representative of the insured, including a member of the insured’s immediate family designated by the insured, making a claim under a policy.
(5) “Ongoing” or “Concurrent care” decision means an insurer has approved an ongoing course of treatment to be provided over a period of time or number of treatments.
(6) “Days” means calendar days.
(7) “Documentation” means a document, record, or other information that is considered relevant to a claimant’s claim because such document, record, or other information:
(a) was relied upon in making the benefit determination;
(b) was submitted, considered, or generated in the course of making the benefit determination, without regard to whether such document, record, or other information was relied upon in making the benefit determination; and
(c) in the case of an insurer providing disability income benefits, constitutes a statement of policy or guidance with respect to the insurer concerning the denied treatment option or benefit for the insured’s diagnosis, without regard to whether such advice or statement was relied upon in making the benefit determination.
(8) “General business practice” means a pattern of conduct.
(9) “Investigation” means all activities of an insurer directly or indirectly related to the determination of liabilities under coverage afforded by an insurance policy.
(10) “Medical necessity” means:
(a) health care services or product that a prudent health care professional would provide to a patient for the purpose of preventing, diagnosing or treating an illness, injury, disease or its symptoms in a manner that is:
(i) in accordance with generally accepted standards of medical practice in the United States;
(ii) clinically appropriate in terms of type, frequency, extent, site, and duration;
(iii) not primarily for the convenience of the patient, physician, or other health care provider; and
(iv) covered under the contract; and
(b) when a medical question-of-fact exists, medical necessity shall include the most appropriate available supply or level of service for the individual in question, considering potential benefits and harms to the individual, and known to be effective.
(i) For an intervention not yet in widespread use, the effectiveness shall be based on scientific evidence.
(ii) For an established intervention, the effectiveness shall be based on:
(A) scientific evidence;
(B) professional standards; and
(C) expert opinion.
(11) “Notice of Loss” means that notice which is in accordance with policy provisions and insurer practices. Such notice shall include any notification, whether in writing or other means, which reasonably apprizes the insurer of the existence of or facts relating to a claim.
(12) “Pre-service claim” means any claim for a benefit under an accident and health policy with respect to which the terms of the plan condition receipt of the benefit, in whole or in part, on approval of the benefit in advance of obtaining medical care.
(13) “Post-service claim” means any claim for a benefit that is not a pre-service claim or urgent care claim.
(14) “Scientific evidence” is:
(a)(i) scientific studies published in or accepted for publication by medical journals that meet nationally recognized requirements for scientific manuscripts and that submit most of their published articles for review by experts who are not part of the editorial staff; or
(ii) findings, studies or research conducted by or under the auspices of federal government agencies and nationally recognized federal research institutes;
(b) scientific evidence shall not include published peer-reviewed literature sponsored to a significant extent by a pharmaceutical manufacturing company or medical device manufacturer or a single study without other supportable studies.
(15) “Urgent care claim” means any claim for medical care or treatment with respect to which the application of the time periods for making non-urgent care determination:
(a) could seriously jeopardize the life or health of the insured or the ability of the insured to regain maximum function; or
(b) in the opinion of a physician with knowledge of the insured’s medical condition, would subject the insured to severe pain that cannot be adequately managed without the care or treatment that is the subject of the claim.